Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone

D. M. Ney, D. J. Huss, Melanie Gillingham, K. R. Kritsch, E. M. Dahly, J. L. Talamantez, M. L. Adamo

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

To investigate the ability of insulin-like growth factor-I (IGF-I), but not GH, to stimulate jejunal growth, we compared indices of IGF-I and insulin receptor expression in jejunal membranes from rats maintained with total parenteral nutrition (TPN) and treated with rhIGF-I and/or rhGH. TPN without growth factor treatment (TPN control) induced jejunal atrophy, reduced serum IGF-I, increased serum insulin concentrations, and increased IGF-I receptor number, IGF-I receptor messenger RNA, and insulin-specific binding to 133% to 170% of the orally fed reference values, P <0.01. Compared with TPN control, IGF-I or IGF-I + GH stimulated jejunal mucosal hyperplasia; IGF-I treatment increased serum IGF-I by 2- to 3-fold and decreased serum insulin concentrations by 60%, decreased IGF-I receptor number by 50% (P <0.001), and increased insulin receptor affinity and insulin receptor protein content. Treatment with GH alone increased serum IGF-I concentration, did not alter TPN-induced jejunal atrophy, and decreased insulin-specific binding and insulin receptor protein content (39% and 59%, respectively, of the TPN control values, P <0.01). We conclude that: 1) jejunal IGF-I receptor content reflects circulating concentration of ligand and is not limiting for jejunal growth; and 2) increased circulating concentration of IGF-I may promote jejunal growth via interaction with jejunal, insulin or IGF-I receptors.

Original languageEnglish (US)
Pages (from-to)4850-4860
Number of pages11
JournalEndocrinology
Volume140
Issue number10
StatePublished - 1999
Externally publishedYes

Fingerprint

IGF Type 1 Receptor
Insulin Receptor
Jejunum
Insulin-Like Growth Factor I
Growth Hormone
Total Parenteral Nutrition
Insulin
Serum
Atrophy
Growth
Nutritive Value
Hyperplasia
Intercellular Signaling Peptides and Proteins
Reference Values
Proteins
Therapeutics
Ligands
Messenger RNA
Membranes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone. / Ney, D. M.; Huss, D. J.; Gillingham, Melanie; Kritsch, K. R.; Dahly, E. M.; Talamantez, J. L.; Adamo, M. L.

In: Endocrinology, Vol. 140, No. 10, 1999, p. 4850-4860.

Research output: Contribution to journalArticle

Ney, D. M. ; Huss, D. J. ; Gillingham, Melanie ; Kritsch, K. R. ; Dahly, E. M. ; Talamantez, J. L. ; Adamo, M. L. / Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone. In: Endocrinology. 1999 ; Vol. 140, No. 10. pp. 4850-4860.
@article{531fd40c20c1431d89ccc9e5b37e23fe,
title = "Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone",
abstract = "To investigate the ability of insulin-like growth factor-I (IGF-I), but not GH, to stimulate jejunal growth, we compared indices of IGF-I and insulin receptor expression in jejunal membranes from rats maintained with total parenteral nutrition (TPN) and treated with rhIGF-I and/or rhGH. TPN without growth factor treatment (TPN control) induced jejunal atrophy, reduced serum IGF-I, increased serum insulin concentrations, and increased IGF-I receptor number, IGF-I receptor messenger RNA, and insulin-specific binding to 133{\%} to 170{\%} of the orally fed reference values, P <0.01. Compared with TPN control, IGF-I or IGF-I + GH stimulated jejunal mucosal hyperplasia; IGF-I treatment increased serum IGF-I by 2- to 3-fold and decreased serum insulin concentrations by 60{\%}, decreased IGF-I receptor number by 50{\%} (P <0.001), and increased insulin receptor affinity and insulin receptor protein content. Treatment with GH alone increased serum IGF-I concentration, did not alter TPN-induced jejunal atrophy, and decreased insulin-specific binding and insulin receptor protein content (39{\%} and 59{\%}, respectively, of the TPN control values, P <0.01). We conclude that: 1) jejunal IGF-I receptor content reflects circulating concentration of ligand and is not limiting for jejunal growth; and 2) increased circulating concentration of IGF-I may promote jejunal growth via interaction with jejunal, insulin or IGF-I receptors.",
author = "Ney, {D. M.} and Huss, {D. J.} and Melanie Gillingham and Kritsch, {K. R.} and Dahly, {E. M.} and Talamantez, {J. L.} and Adamo, {M. L.}",
year = "1999",
language = "English (US)",
volume = "140",
pages = "4850--4860",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone

AU - Ney, D. M.

AU - Huss, D. J.

AU - Gillingham, Melanie

AU - Kritsch, K. R.

AU - Dahly, E. M.

AU - Talamantez, J. L.

AU - Adamo, M. L.

PY - 1999

Y1 - 1999

N2 - To investigate the ability of insulin-like growth factor-I (IGF-I), but not GH, to stimulate jejunal growth, we compared indices of IGF-I and insulin receptor expression in jejunal membranes from rats maintained with total parenteral nutrition (TPN) and treated with rhIGF-I and/or rhGH. TPN without growth factor treatment (TPN control) induced jejunal atrophy, reduced serum IGF-I, increased serum insulin concentrations, and increased IGF-I receptor number, IGF-I receptor messenger RNA, and insulin-specific binding to 133% to 170% of the orally fed reference values, P <0.01. Compared with TPN control, IGF-I or IGF-I + GH stimulated jejunal mucosal hyperplasia; IGF-I treatment increased serum IGF-I by 2- to 3-fold and decreased serum insulin concentrations by 60%, decreased IGF-I receptor number by 50% (P <0.001), and increased insulin receptor affinity and insulin receptor protein content. Treatment with GH alone increased serum IGF-I concentration, did not alter TPN-induced jejunal atrophy, and decreased insulin-specific binding and insulin receptor protein content (39% and 59%, respectively, of the TPN control values, P <0.01). We conclude that: 1) jejunal IGF-I receptor content reflects circulating concentration of ligand and is not limiting for jejunal growth; and 2) increased circulating concentration of IGF-I may promote jejunal growth via interaction with jejunal, insulin or IGF-I receptors.

AB - To investigate the ability of insulin-like growth factor-I (IGF-I), but not GH, to stimulate jejunal growth, we compared indices of IGF-I and insulin receptor expression in jejunal membranes from rats maintained with total parenteral nutrition (TPN) and treated with rhIGF-I and/or rhGH. TPN without growth factor treatment (TPN control) induced jejunal atrophy, reduced serum IGF-I, increased serum insulin concentrations, and increased IGF-I receptor number, IGF-I receptor messenger RNA, and insulin-specific binding to 133% to 170% of the orally fed reference values, P <0.01. Compared with TPN control, IGF-I or IGF-I + GH stimulated jejunal mucosal hyperplasia; IGF-I treatment increased serum IGF-I by 2- to 3-fold and decreased serum insulin concentrations by 60%, decreased IGF-I receptor number by 50% (P <0.001), and increased insulin receptor affinity and insulin receptor protein content. Treatment with GH alone increased serum IGF-I concentration, did not alter TPN-induced jejunal atrophy, and decreased insulin-specific binding and insulin receptor protein content (39% and 59%, respectively, of the TPN control values, P <0.01). We conclude that: 1) jejunal IGF-I receptor content reflects circulating concentration of ligand and is not limiting for jejunal growth; and 2) increased circulating concentration of IGF-I may promote jejunal growth via interaction with jejunal, insulin or IGF-I receptors.

UR - http://www.scopus.com/inward/record.url?scp=0033304867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033304867&partnerID=8YFLogxK

M3 - Article

C2 - 10499545

AN - SCOPUS:0033304867

VL - 140

SP - 4850

EP - 4860

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 10

ER -